Blood lipids and lipoproteins in relation to incidence and mortality risks for CVD and cancer in the prospective EPIC–Heidelberg cohort

Figures

• 

  Fig. 1. Correlation matrix of covariates with lipid biomarkers in the EPIC–Heidelberg subcohort (n = 2739). Red depicts negative correlation, blue depicts positive correlation; the darker the shade the stronger the correlation. apo apolipoprotein, HDL high-density lipoprotein, Lp(a) lipoprotein a, TC total cholesterol, TG triglycerides

• 

  Fig. 2. Associations of lipid biomarkers with site-specific cancer incidence and total cancer mortality, multivariable adjusted for sex, age at blood draw, baseline height, waist, BMI, lifetime alcohol consumption, red meat intake, fiber intake, smoking status, socioeconomic status, physical activity, diabetes, hypertension, and use of lipid-lowering drugs. Q quartile, apo apolipoprotein, CI confidence interval, HDL high-density lipoprotein, Lp(a) lipoprotein a, TC total cholesterol, TG triglycerides

• 

  Fig. 3. Associations of lipid biomarkers with incident myocardial infarction, incident stroke, and cardiovascular mortality, multivariable adjusted for sex, age at blood draw, baseline height, waist, BMI, lifetime alcohol consumption, red meat intake, fiber intake, smoking status, socioeconomic status, physical activity, diabetes, hypertension, and use of lipid-lowering drugs. apo apolipoprotein, CI confidence interval, HDL high-density lipoprotein, Lp(a) lipoprotein (a), Q quartile, TC total cholesterol, TG triglycerides